U.S. Coca-Cola, Nextera Energy Partners, ServiceNow
Oct 24 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Coca-Cola, Nextera Energy Partners, and ServiceNow on Thursday.
HIGHLIGHTS
* Avery Dennison Corp AVY.N: JP Morgan cuts to neutral from overweight |
* Coca-Cola Co KO.N: JP Morgan cuts target price to $75 from $78 |
* Nextera Energy Partners LP NEP.N: JP Morgan raises to neutral from underweight |
* ServiceNow Inc NOW.N: JP Morgan raises target price to $950 from $820 |
* Thermo Fisher Scientific Inc TMO.N: Leerink Partners cuts PT to $620 from $645 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Airsculpt Technologies Inc AIRS.O: Piper Sandler raises target price to $4 from $3 |
* Align Technology Inc ALGN.O: Leerink Partners cuts target price to $235 from $257 |
* Align Technology Inc ALGN.O: Morgan Stanley cuts target price to $280 from $310 |
* Align Technology Inc ALGN.O: Piper Sandler cuts target price to $275 from $285 |
* Align Technology Inc ALGN.O: Stifel cuts target price to $275 from $285 |
* Alliant Energy Corp LNT.O: BMO raises target price to $65 from $60 |
* Ameren Corp AEE.N: BMO raises target price to $95 from $87 |
* Amphenol Corp APH.N: JP Morgan raises target price to $85 from $80 |
* Amphenol Corp APH.N: Truist Securities raises target price to $82 from $76 |
* Amphenol Corp APH.N: UBS raises target price to $81 from $80 |
* Apellis Pharmaceuticals Inc APLS.O: Mizuho cuts target price to $38 from $39 |
* ASGN Inc ASGN.N: UBS raises target price to $72 from $70 |
* AT&T Inc T.N: Barclays raises target price to $24 from $22 |
* AT&T Inc T.N: JP Morgan raises target price to $25 from $24 |
* AT&T Inc T.N: Oppenheimer raises target price to $24 from $23 |
* AT&T Inc T.N: TD Cowen raises target price to $26 from $23 |
* AT&T Inc T.N: UBS raises target price to $25 from $24 |
* AT&T Inc T.N: Wells Fargo cuts target price to $24 from $25 |
* ATI Inc ATI.N: KeyBanc cuts to sector weight from overweight |
* Avalo Therapeutics Inc AVTX.O: H.C. Wainwright initiates coverage with neutral rating |
* Avalonbay Communities Inc AVB.N: Mizuho raises target price to $239 from $194 |
* Avery Dennison Corp AVY.N: BMO cuts target price to $247 from $252 |
* Avery Dennison Corp AVY.N: JP Morgan cuts target price to $210 from $230 |
* Avery Dennison Corp AVY.N: JP Morgan cuts to neutral from overweight |
* Avery Dennison Corp AVY.N: Raymond James cuts target price to $235 from $240 |
* Avis Budget Group Inc CAR.O: Deutsche Bank cuts target price to $145 from $146 |
* Baker Hughes Co BKR.O: Barclays raises target price to $46 from $41 |
* Baker Hughes Co BKR.O: Susquehanna raises target price to $48 from $46 |
* Banc of California Inc BANC.N: Stephens raises target price to $16 from $15 |
* Blackstone Mortgage Trust Inc BXMT.N: JP Morgan raises target price to $18.5 from $17 |
* Blueprint Medicines BPMC.O: UBS initiates coverage with neutral rating and PT $88 |
* Boeing BA.N: Wells Fargo cuts target price to $86 from $109 |
* Boeing BA.N: UBS cuts target price to $195 from $215 |
* Booking Holdings Inc BKNG.O: Mizuho raises target price to $4800 from $4250 |
* Boston Scientific Corp BSX.N: Bernstein raises target price to $100 from $92 |
* Boston Scientific Corp BSX.N: Citigroup raises target price to $98 from $92 |
* Boston Scientific Corp BSX.N: Deutsche Bank raises target price to $87 from $78 |
* Boston Scientific Corp BSX.N: Jefferies raises target price to $100 from $90 |
* Boston Scientific Corp BSX.N: Mizuho raises target price to $110 from $100 |
* Boston Scientific Corp BSX.N: Raymond James raises target price to $101 from $94 |
* Boston Scientific Corp BSX.N: UBS raises target price to $102 from $94 |
* Boston Scientific Corp BSX.N: Wells Fargo raises target price to $98 from $87 |
* Camden Property Trust CPT.N: Mizuho raises target price to $129 from $108 |
* Capitol Federal Financial Inc CFFN.O: KBW raises target price to $7 from $6.5 |
* Caretrust REIT Inc CTRE.N: Raymond James raises target price to $35 from $33 |
* CBRE Group Inc CBRE.N: KBW raises target price to $125 from $120 |
* CBRE Group Inc CBRE.N: Raymond James raises target price to $142 from $129 |
* Celestica Inc CLS.N: Cormark Securities raises target price to $71 from $64 |
* Century Communities Inc CCS.N: Wedbush raises target price to $96 from $90 |
* CG Oncology Inc CGON.O: UBS initiates coverage with buy rating and target price $60 |
* Charles Schwab Corp SCHW.N: Morgan Stanley raises target price to $74 from $68 |
* CME Group Inc CME.O: Barclays raises target price to $231 from $219 |
* CME Group Inc CME.O: Citigroup raises target price to $255 from $250 |
* CME Group Inc CME.O: Deutsche Bank raises target price to $227 from $224 |
* CME Group Inc CME.O: KBW raises target price to $237 from $236 |
* CME Group Inc CME.O: Oppenheimer raises target price to $258 from $245 |
* CME Group Inc CME.O: TD Cowen raises target price to $239 from $219 |
* CMS Energy Corp CMS.N: BMO raises target price to $77 from $76 |
* Coca-Cola Co KO.N: Deutsche Bank cuts target price to $68 from $69 |
* Coca-Cola Co KO.N: Jefferies raises target price to $77 from $73 |
* Coca-Cola Co KO.N: JP Morgan cuts target price to $75 from $78 |
* Coca-Cola Co KO.N: Morgan Stanley cuts target price to $76 from $78 |
* Coca-Cola Co KO.N: RBC raises target price to $71 from $68 |
* Community Health Systems Inc CYH.N: Barclays raises target price to $5 from $3 |
* Costar Group Inc CSGP.O: BMO cuts target price to $75 from $78 |
* Costar Group Inc CSGP.O: Citigroup cuts target price to $90 from $97 |
* Cullinan Therapeutics CGEM.O: UBS initiates coverage with buy rating and PT $30 |
* CVS Health Corp CVS.N: Mizuho cuts target price to $66 from $73 |
* Dominion Energy D.N: BMO raises target price to $60 from $57 |
* Doordash DASH.O: Mizuho raises target price to $173 from $162 |
* Duke Energy Corp DUK.N: BMO raises target price to $128 from $126 |
* Dyne Therapeutics Inc DYN.O: JP Morgan cuts target price to $35 from $43 |
* Dyne Therapeutics Inc DYN.O: JP Morgan cuts to neutral from overweight |
* East West Bancorp Inc EWBC.O: Stephens raises target price to $104 from $91 |
* eBay EBAY.O: Bernstein raises target price to $70 from $60 |
* eBay EBAY.O: UBS raises target price to $72 from $59 |
* Elf Beauty Inc ELF.N: Stifel cuts target price to $131 from $161 |
* Enphase Energy Inc ENPH.O: Barclays cuts target price to $114 from $129 |
* Enphase Energy Inc ENPH.O: BMO cuts target price to $85 from $104 |
* Ensign Group Inc ENSG.O: Stephens raises target price to $163 from $155 |
* Entergy ETR.N: BMO raises target price to $146 from $140 |
* Equifax Inc EFX.N: Citigroup cuts target price to $318 from $331 |
* Equity Residential EQR.N: Mizuho raises target price to $78 from $64 |
* Essex Property Trust Inc ESS.N: Mizuho raises target price to $325 from $266 |
* Estée Lauder EL.N: TD Cowen cuts target price to $95 from $110 |
* Etsy Inc ETSY.O: BofA Global Research cuts price objective to $58 from $61 |
* Eversource Energy ES.N: BMO raises target price to $75 from $72 |
* Exelon Corp EXC.O: BMO raises target price to $47 from $45 |
* First Bancorp FBP.N: Wells Fargo cuts target price to $20 from $22 |
* First Busey Corp BUSE.O: KBW cuts target price to $32 from $33 |
* First Busey Corp BUSE.O: Raymond James cuts target price to $29 from $31 |
* First Financial Corp THFF.O: KBW raises target price to $46 from $44 |
* Fiserv Inc FI.N: Mizuho raises target price to $222 from $183 |
* GE Vernova Inc GEV.N: Barclays raises target price to $320 from $300 |
* GE Vernova Inc GEV.N: BofA Global Research raises PT to $320 from $300 |
* GE Vernova Inc GEV.N: JP Morgan raises target price to $330 from $285 |
* GE Vernova Inc GEV.N: Morgan Stanley raises target price to $301 from $256 |
* General Dynamics Corp GD.N: Bernstein cuts target price to $331 from $343 |
* General Dynamics Corp GD.N: Deutsche Bank cuts target price to $309 from $314 |
* General Dynamics Corp GD.N: RBC raises target price to $330 from $320 |
* General Dynamics Corp GD.N: UBS raises target price to $337 from $324 |
* General Dynamics Corp GD.N: Vertical Research raises target price to $332 from $329 |
* General Dynamics Corp GD.N: Wells Fargo raises target price to $322 from $317 |
* Globe Life Inc GL.N: Morgan Stanley raises target price to $120 from $110 |
* GM GM.N: Barclays raises target price to $70 from $64 |
* GM GM.N: Bernstein raises target price to $55 from $53 |
* Goosehead Insurance Inc GSHD.O: KBW raises target price to $110 from $95 |
* Greenbrier Companies Inc GBX.N: BofA Global Research ups PT to $50 from $42 |
* Hanmi Financial Corp HAFC.O: Piper Sandler raises target price to $25.5 from $20 |
* Hanmi Financial Corp HAFC.O: Piper Sandler raises to overweight from neutral |
* Hertz Global Holdings HTZ.O: Deutsche Bank cuts target price to $3.2 from $3.85 |
* Hexcel Corporation HXL.N: Deutsche Bank raises target price to $64 from $62 |
* Hilton Worldwide Holdings Inc HLT.N: Barclays cuts target price to $243 from $244 |
* Hilton Worldwide Holdings Inc HLT.N: Deutsche Bank raises PT to $200 from $181 |
* Hilton Worldwide Holdings Inc HLT.N: Jefferies raises target price to $237 from $213 |
* Hilton Worldwide Holdings Inc HLT.N: Mizuho raises target price to $243 from $237 |
* Hilton Worldwide Holdings Inc HLT.N: Truist Securities raises PT to $220 from $208 |
* Hilton Worldwide Holdings Inc HLT.N: Wells Fargo cuts target price to $232 from $237 |
* Howmet Aerospace HWM.N: KeyBanc cuts to sector weight from overweight |
* IBM IBM.N: BMO raises target price to $260 from $235 |
* IBM IBM.N: Melius Research raises target price to $255 from $222 |
* IBM IBM.N: Morgan Stanley cuts target price to $208 from $217 |
* Ideaya Biosciences Inc IDYA.O: UBS initiates coverage with buy rating and PT $50 |
* Illinois Tool Works Inc ITW.N: JP Morgan raises target price to $295 from $270 |
* Impinj Inc PI.O: Needham raises target price to $245 from $195 |
* Intellia Therapeutics Inc NTLA.O: Baird cuts target price to $18 from $24 |
* International Business Machines Corp IBM.N: UBS raises PT to $150 from $145 |
* International Flavors & Fragrances Inc IFF.N: Stifel raises PT to $121 from $115 |
* Iovance Biotherapeutics Inc IOVA.O: UBS initiates coverage with buy rating and PT $17 |
* Janux Therapeutics Inc JANX.O: UBS initiates coverage with buy rating and PT $69 |
* Jll JLL.N: KBW raises target price to $280 from $250 |
* Jll JLL.N: Raymond James raises target price to $301 from $277 |
* Kinetik Holdings Inc KNTK.N: Mizuho raises target price to $55 from $47 |
* Knight Transportation Inc KNX.N: Morgan Stanley cuts target price to $70 from $72 |
* Knight-Swift Transportation Holdings Inc KNX.N: TD Cowen raises PT to $56 from $55 |
* Kura Oncology Inc KURA.O: UBS initiates coverage with buy rating and target price $27 |
* Lam Research LRCX.O: BofA Global Research raises price objective to $92 from $88 |
* Lam Research LRCX.O: Jefferies cuts target price to $95 from $110 |
* Lam Research LRCX.O: Morgan Stanley cuts target price to $76.00 from $77.00 |
* Lam Research Corp LRCX.O: Deutsche Bank cuts target price to $75 from $88 |
* Lam Research Corp LRCX.O: Stifel cuts target price to $100 from $105 |
* Lam Research Corp LRCX.O: UBS cuts target price to $105 from $115 |
* Lam Research Corp LRCX.O: Wells Fargo cuts target price to $85 from $88 |
* Las Vegas Sands Corp LVS.N: Deutsche Bank raises target price to $60 from $55 |
* Las Vegas Sands Corp LVS.N: Mizuho raises target price to $57 from $52 |
* Las Vegas Sands Corp LVS.N: Stifel raises target price to $64 from $55 |
* Lendingclub Corp LC.N: Jefferies raises target price to $16 from $15 |
* Lendingclub Corp LC.N: Wedbush raises target price to $17 from $14 |
* Lennox International Inc LII.N: Barclays raises target price to $624 from $575 |
* Lennox International Inc LII.N: JP Morgan raises target price to $536 from $522 |
* Lennox International Inc LII.N: Mizuho raises target price to $675 from $650 |
* Lennox International Inc LII.N: RBC raises target price to $619 from $604 |
* Lithia Motors Inc LAD.N: Guggenheim raises target price to $380 from $350 |
* Lithia Motors Inc LAD.N: Stephens raises target price to $405 from $360 |
* Live Nation Entertainment Inc LYV.N: JP Morgan raises target price to $137 from $118 |
* Lumos Pharma Inc LUMO.O: H.C. Wainwright cuts target price to $4.25 from $28 |
* Lumos pharma Inc LUMO.O: H.C. Wainwright cuts to neutral from buy |
* Matador Resources Co MTDR.N: JP Morgan cuts target price to $77 from $79 |
* Matador Resources Co MTDR.N: Raymond James raises target price to $71 from $68 |
* Mattel Inc MAT.O: Morgan Stanley raises target price to $22 from $21 |
* Maxlinear Inc MXL.O: Craig-Hallum cuts target price to $25 from $28 |
* McDonald's MCD.N: Baird cuts target price to $290 from $320 |
* McDonald's MCD.N: Baird cuts to neutral rating |
* Medpace Holdings Inc MEDP.O: Baird cuts target price to $349 from $413 |
* Medpace Holdings Inc MEDP.O: Baird cuts to neutral rating |
* Merus NV MRUS.O: UBS initiates coverage with buy rating; target price $72 |
* Mid-America Apartment Communities MAA.N: Mizuho raises PT to $163 from $130 |
* Moderna Inc MRNA.O: UBS cuts target price to $108 from $140 |
* Moelis & Co MC.N: KBW raises target price to $71 from $65 |
* Moelis & Co MC.N: Morgan Stanley cuts target price to $66 from $67 |
* Monarch Casino & Resort Inc MCRI.O: Stifel raises target price to $77 from $72 |
* Moody's Corp MCO.N: BMO raises target price to $468 from $464 |
* National Bank Holdings Corp NBHC.N: D.A. Davidson raises target price to $53 from $51 |
* National Bank Holdings Corp NBHC.N: Stephens raises target price to $49 from $46 |
* Newmark Group Inc NMRK.O: KBW raises target price to $17 from $16.5 |
* Nextera Energy Inc NEE.N: Guggenheim raises target price to $92 from $90 |
* Nextera Energy Inc NEE.N: UBS raises target price to $96 from $90 |
* Nextera Energy Partners LP NEP.N: Jefferies cuts target price to $27 from $28 |
* Nextera Energy Partners LP NEP.N: JP Morgan cuts target price to $22 from $25 |
* Nextera Energy Partners LP NEP.N: JP Morgan raises to neutral from underweight |
* Nextera Energy Partners LP NEP.N: Mizuho cuts target price to $23 from $26 |
* Nextracker Inc NXT.O: Jefferies cuts target price to $37 from $46 |
* NiSource Inc NI.N: BMO raises target price to $37 from $36 |
* Northern Trust Corp NTRS.O: Barclays raises target price to $115 from $98 |
* Northern Trust Corp NTRS.O: Deutsche Bank raises target price to $100 from $90 |
* Northern Trust Corp NTRS.O: KBW raises target price to $100 from $92 |
* Northern Trust Corp NTRS.O: Morgan Stanley raises target price to $103 from $97 |
* Northern Trust Corp NTRS.O: RBC raises target price to $107 from $100 |
* Northern Trust Corporation NTRS.O: Wells Fargo raises target price to $108 from $92 |
* Nurix Therapeutics Inc NRIX.O: UBS initiates coverage with buy rating and PT $35 |
* Nuvalent Inc NUVL.O: UBS initiates coverage with neutral rating and target price $100 |
* Old Dominion Freight Line Inc ODFL.O: Barclays cuts target price to $190 from $195 |
* Old Dominion Freight Line Inc ODFL.O: BMO cuts target price to $205 from $210 |
* Old Dominion Freight Line Inc ODFL.O: JP Morgan cuts target price to $186 from $191 |
* Old Dominion Freight Line Inc ODFL.O: Raymond James cuts PT to $200 from $205 |
* Old Dominion Freight Line Inc ODFL.O: Stifel cuts target price to $178 from $197 |
* Old Dominion Freight Line Inc ODFL.O: TD Cowen cuts target price to $196 from $203 |
* Old Dominion Freight Line Inc ODFL.O: UBS raises target price to $196 from $185 |
* Old Dominion Freight Line Inc ODFL.O: Wells Fargo cuts target price to $160 from $170 |
* Omega Healthcare Investors Inc OHI.N: Raymond James raises PT to $44 from $41 |
* O'Reilly Automotive ORLY.O: Morgan Stanley raises target price to $1150 from $1100 |
* Packaging Corp of America PKG.N: Truist Securities raises PT to $252 from $242 |
* Packaging Corp of America PKG.N: Wells Fargo raises target price to $253 from $235 |
* Pacs Group Inc PACS.N: Stephens raises target price to $48 from $43 |
* Pathward Financial Inc CASH.O: KBW raises target price to $76 from $72 |
* Peapack-Gladstone Financial Corp PGC.O: KBW raises target price to $38 from $33.5 |
* Peapack-Gladstone Financial Corp PGC.O: Piper Sandler raises PT to $35 from $30 |
* Peapack-Gladstone Financial Corp PGC.O: Piper Sandler raises to overweight from neutral |
* Pennymac Financial Services Inc PFSI.N: KBW cuts target price to $112 from $115 |
* Pennymac Financial Services Inc PFSI.N: Wells Fargo raises PT to $125 from $110 |
* Perspective Therapeutics Inc CATX.A: UBS initiates coverage with buy rating; PT $20 |
* PG&E Corp PCG.N: JP Morgan raises target price to $25 from $23 |
* Popular Inc BPOP.O: UBS cuts target price to $100 from $102 |
* Popular Inc BPOP.O: Wells Fargo cuts target price to $98 from $105 |
* Primo Water Corp PRMW.N: William Blair initiates coverage with outperform rating |
* Prog Holdings Inc PRG.N: Raymond James raises to outperform from market perform |
* Prologis Inc PLD.N: BMO cuts target price to $120 from $122 |
* Pros Holdings Inc PRO.N: Oppenheimer cuts target price to $27 from $31 |
* Prosperity Bancshares Inc PB.N: Raymond James raises target price to $82 from $80 |
* Public Service Enterprise Group Inc PEG.N: BMO raises target price to $90 from $89 |
* Pultegroup Inc PHM.N: JP Morgan raises target price to $162 from $152 |
* PVH Corp PVH.N: Jefferies cuts target price to $104 from $108 |
* Q32 Bio Inc QTTB.O: Raymond James initiates coverage with strong buy rating; PT $90 |
* Qualys Inc QLYS.O: Morgan Stanley cuts target price to $123 from $136 |
* Quest Diagnostics Inc DGX.N: Baird raises target price to $182 from $157 |
* Quest Diagnostics Inc DGX.N: Baird raises to outperform rating |
* Quest Diagnostics Inc DGX.N: Mizuho raises target price to $174 from $160 |
* Ralph Lauren Corp RL.N: Jefferies raises target price to $230 from $195 |
* Range Resources Corp RRC.N: JP Morgan raises target price to $34 from $33 |
* Raymond James Financial Inc RJF.N: BofA Global Research raises PT to $152 from $136 |
* Raymond James Financial Inc RJF.N: Jefferies raises target price to $135 from $126 |
* Raymond James Financial Inc RJF.N: JP Morgan raises target price to $151 from $137 |
* Raymond James Financial Inc RJF.N: KBW raises target price to $143 from $135 |
* Raymond James Financial Inc RJF.N: UBS raises target price to $140 from $132 |
* Raymond James Financial Inc RJF.N: Wells Fargo raises target price to $152 from $140 |
* Regeneron Pharmaceuticals Inc REGN.O: JP Morgan cuts target price to $1150 from $1200 |
* Regions Financial RF.N: Deutsche Bank cuts target price to $24 from $26 |
* Regions Financial RF.N: Deutsche Bank raises to buy from hold |
* RLI Corp RLI.N: KBW raises target price to $180 from $176 |
* Rocket Lab USA Inc RKLB.O: KeyBanc raises target price to $12 from $11 |
* Roper Technologies Inc ROP.O: Truist Securities raises target price to $665 from $660 |
* Salesforce Inc CRM.N: Oppenheimer raises target price to $330 from $300 |
* Sallie Mae SLM.O: Barclays cuts target price to $26 from $27 |
* Sally Beauty Holdings Inc SBH.N: TD Cowen raises target price to $13 from $12 |
* Schlumberger NV SLB.N: UBS cuts target price to $54 from $57 |
* SEI Investments Co SEIC.O: KBW raises target price to $76 from $73 |
* SEI Investments Co SEIC.O: Morgan Stanley raises target price to $75 from $70 |
* SEI Investments Co SEIC.O: Oppenheimer raises target price to $85 from $81 |
* Seres Therapeutics Inc MCRB.O: JP Morgan cuts to underweight from neutral |
* ServiceNow Inc NOW.N: Baird raises target price to $975 from $900 |
* ServiceNow Inc NOW.N: Barclays raises target price to $1000 from $980 |
* ServiceNow Inc NOW.N: Bernstein raises target price to $913 from $906 |
* ServiceNow Inc NOW.N: Canaccord Genuity raises target price to $1,000 from $850 |
* ServiceNow Inc NOW.N: JP Morgan raises target price to $950 from $820 |
* ServiceNow Inc NOW.N: Needham raises target price to $1075 from $900 |
* ServiceNow Inc NOW.N: Piper Sandler raises target price to $1000 from $850 |
* ServiceNow Inc NOW.N: RBC raises target price to $1045 from $985 |
* ServiceNow Inc NOW.N: Stifel raises target price to $990 from $900 |
* ServiceNow Inc NOW.N: Wells Fargo raises target price to $1,050 from $1,025 |
* Sherwin-Williams Co SHW.N: Citigroup cuts target price to $420 from $430 |
* Sirius XM Holdings SIRI.O: BofA Global Research resumes coverage with PT $23 |
* Sirius XM Holdings SIRI.O: BofA Global Research resumes coverage with underperform rating |
* SLM Corp SLM.O: Deutsche Bank raises target price to $32 from $29 |
* South Plains Financial Inc SPFI.O: KBW raises target price to $39 from $37 |
* South Plains Financial Inc SPFI.O: Raymond James raises target price to $37 from $34 |
* Southern Co SO.N: BMO raises target price to $99 from $94 |
* Sprout Social Inc SPT.O: Oppenheimer cuts target price to $40 from $43 |
* Stifel Financial Corp SF.N: Wells Fargo raises target price to $113 from $108 |
* Stock Yards Bancorp Inc SYBT.O: Stephens raises target price to $70 from $60 |
* Stride Inc LRN.N: BMO raises target price to $88 from $84 |
* Syndax Pharmaceuticals Inc SNDX.O: UBS initiates coverage with buy rating |
* Syndax Pharmaceuticals Inc SNDX.O: UBS initiates coverage with target price $37 |
* Synopsys Inc SNPS.O: Piper Sandler cuts target price to $670 from $687 |
* Take-Two Interactive Software Inc TTWO.O: Moffettnathanson cuts PT to $155 from $168 |
* Taylor Morrison Home Corp TMHC.N: Barclays raises target price to $75 from $72 |
* Taylor Morrison Home Corp TMHC.N: BTIG raises target price to $86 from $78 |
* Teledyne Technologies Inc TDY.N: Needham raises target price to $528 from $482 |
* Teledyne Technologies Inc TDY.N: TD Cowen raises target price to $500 from $450 |
* Tesla Inc TSLA.O: BofA Global Research raises price objective to $265 from $255 |
* Tesla Inc TSLA.O: Canaccord Genuity raises target price to $278 from $254 |
* Tesla Inc TSLA.O: Guggenheim raises target price to $156 from $153 |
* Tesla Inc TSLA.O: JP Morgan raises target price to $135 from $130 |
* Tesla Inc TSLA.O: RBC raises target price to $249 from $236 |
* Tesla Inc TSLA.O: Truist Securities raises target price to $238 from $236 |
* Tesla Inc TSLA.O: Wells Fargo raises target price to $125 from $120 |
* Thermo Fisher Scientific Inc TMO.N: Barclays cuts target price to $610 from $620 |
* Thermo Fisher Scientific Inc TMO.N: Bernstein cuts target price to $620 from $625 |
* Thermo Fisher Scientific Inc TMO.N: Leerink Partners cuts PT to $620 from $645 |
* Thermo Fisher Scientific Inc TMO.N: Raymond James cuts target price to $650 from $660 |
* Thermo Fisher Scientific Inc TMO.N: RBC cuts target price to $718 from $767 |
* Thermo Fisher Scientific Inc TMO.N: Stifel cuts target price to $665 from $680 |
* Thermo Fisher Scientific Inc TMO.N: Wells Fargo cuts target price to $660 from $670 |
* T-Mobile TMUS.O: Barclays raises target price to $230 from $215 |
* T-Mobile TMUS.O: Benchmark raises target price to $255 |
* T-Mobile TMUS.O: BofA Global Research raises price objective to $240 from $220 |
* T-Mobile TMUS.O: JP Morgan raises target price to $250 from $230 |
* T-Mobile TMUS.O: Oppenheimer raises target price to $250 from $215 |
* T-Mobile TMUS.O: Scotiabank raises target price to $237 from $236 |
* T-Mobile TMUS.O: Wells Fargo raises target price to $240 from $230 |
* T-Mobile TMUS.O: Wolfe Research raises target price to $255 |
* T-Mobile TMUS.O: UBS raises target price to $255 from $210 |
* Transdigm Group Inc TDG.N: KeyBanc raises target price to $1,500 from $1,440 |
* TransUnion TRU.N: JP Morgan raises target price to $124 from $99 |
* TransUnion TRU.N: Morgan Stanley raises target price to $119 from $103 |
* TransUnion TRU.N: Oppenheimer raises target price to $122 from $118 |
* TransUnion TRU.N: Stifel raises target price to $120 from $103 |
* TransUnion TRU.N: UBS raises target price to $112 from $110 |
* TransUnion TRU.N: Wells Fargo raises target price to $135 from $125 |
* Travel + Leisure Co TNL.N: Barclays raises target price to $41 from $40 |
* Travel + Leisure Co TNL.N: Deutsche Bank cuts target price to $59 from $62 |
* Travel + Leisure Co TNL.N: Jefferies raises target price to $62 from $60 |
* Travelzoo TZOO.O: Barrington Research raises target price to $17 |
* Trustmark Corp TRMK.O: KBW raises target price to $41 from $40 |
* UDR Inc UDR.N: Mizuho raises target price to $47 from $38 |
* Under Armour Inc UAA.N: UBS raises target price to $12 from $11 |
* United Parks & Resorts PRKS.N: Deutsche Bank cuts target price to $71 from $74 |
* United Rentals Inc URI.N: BofA Global Research raises PT to $910 from $800 |
* US Bancorp USB.N: Deutsche Bank cuts to hold from buy |
* Valmont Industries Inc VMI.N: Stifel raises target price to $360 from $350 |
* Ventas Inc VTR.N: Raymond James raises target price to $70 from $68 |
* Veritex Holdings Inc VBTX.O: KBW cuts to market perform from outperform |
* Veritex Holdings Inc VBTX.O: KBW raises target price to $30 from $29 |
* Veritex Holdings Inc VBTX.O: Piper Sandler raises target price to $30 from $27 |
* Verizon Communications Inc VZ.N: Deutsche Bank cuts target price to $42 from $44 |
* Verizon Communications Inc VZ.N: KeyBanc cuts to sector weight from overweight |
* Vertiv Holdings Co VRT.N: BofA Global Research ups price objective to $140 from $130 |
* Vertiv Holdings Co VRT.N: Citigroup raises target price to $134 from $130 |
* Vertiv Holdings Co VRT.N: Mizuho raises target price to $125 from $110 |
* Vertiv Holdings Co VRT.N: Oppenheimer raises target price to $121 from $115 |
* Vertiv Holdings Co VRT.N: TD Cowen raises target price to $115 from $93 |
* Viking Therapeutics Inc VKTX.O: Raymond James raises target price to $122 from $118 |
* Wabtec Corp WAB.N: Stephens raises target price to $205 from $190 |
* Walker & Dunlop Inc WD.N: KBW raises target price to $117 from $112 |
* Weatherford International Plc WFRD.O: Raymond James cuts PT to $135 from $140 |
* WEC Energy Group Inc WEC.N: BMO raises target price to $97 from $93 |
* Welltower Inc WELL.N: Raymond James raises target price to $145 from $134 |
* Western Union Co WU.N: UBS cuts target price to $12 from $13.5 |
* Widepoint Corp WYY.A: H.C. Wainwright initiates coverage with buy rating and PT $7 |
* Winnebago Industries Inc WGO.N: BMO cuts target price to $70 from $75 |
* Winnebago Industries Inc WGO.N: Truist Securities cuts target price to $64 from $68 |
* Wyndham Hotels & Resorts Inc WH.N: HSBC raises target price to $93 from $88 |
* Wyndham Hotels & Resorts Inc WH.N: Stifel raises target price to $92 from $91 |
* Xcel Energy XEL.O: BMO raises target price to $70 from $67 |
* Zeta Global Holdings Corp ZETA.N: Oppenheimer raises target price to $33 from $29 |
(Compiled by Bengaluru Newsroom)
</body></html>Các tài sản liên quan
Tin mới
Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.
Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.
Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.